Skip to main content
. 2020 Dec 2;29(4):709–713. doi: 10.1038/s41431-020-00774-w

Table 2.

The most frequently mutated genes accompanied by cnLOH in SCRC.

SCRC MM SCRC MP SCRC PM SCRC PP SCRC p valuea
APC
“1st hit” mutation 33 (44.6) 10 (62.5) 6 (37.5) 9 (37.5) 7 (38.9) NS
“2nd hit” cnLOH 9 (27.3) 4 (40.0) 2 (33.3) 2 (22.2) 1 (14.3) NS
KRAS
“1st hit” mutation 32 (43.2) 5 (31.3) 7 (43.8) 11 (45.8) 9 (50.0) NS
“2nd hit” cnLOH
TP53
“1st hit” mutation 13 (17.6) 4 (25.0) 4 (16.7) 5 (27.8) NS
“2nd hit” cnLOH 1 (7.7) 1 (25.0) 1 (25.0)
FBXW7
“1st hit” mutation 7 (9.5) 3 (18.8) 1 (6.3) 1 (4.2) 2 (27.8) NS
“2nd hit” cnLOH 1 (14.3) 1 (50.0)
SMAD4
“1st hit” mutation 4 (5.4) 3 (18.8) 1 (5.6) 0.049
“2nd hit” cnLOH

aStatistical analysis was performed by Pearson’s chi square (χ2) test. Parentheses refer to percentage numbers. cnLOH copy neutral loss of heterozygosity, SCRC synchronous colorectal cancer, MM monoclonal monosegmental, MP monoclonal pancolonic, PM polyclonal monosegmental, PP polyclonal pancolonic, NS not significant.